This inventor holds 14 USPTO granted patents and 1 published patent application, plus 4 CIPO patents and 9 EPO patents. Top assignees: Askat Inc., Raqualia Pharma Inc., Cj Healthcare Corporation. Active years: 2014-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
7 out of 15 
6 out of 47 
1 out of 14 Years Active: 2014-2023
Title: Innovations and Contributions of Inventor Shinichi Koizumi
Introduction: Shinichi Koizumi, based in Aichi, Japan, is a prominent inventor with a remarkable portfolio of 14 patents. He has made significant contributions to the medical field, particularly in the treatment of cancer and gastric acid-related diseases. His innovative approach has led to the development of novel pharmaceutical applications that aim to improve patient outcomes.
Latest Patents: Among his recent patents is a groundbreaking invention titled "Selective EP4 receptor antagonistic substance for treatment of cancer." This invention introduces a medicament designed to reduce cancer, utilizing a compound that exhibits inhibitory activities against the prostaglandin E2 receptor (EP4 receptor). The patent outlines a method for treating cancer through the administration of this compound or its pharmaceutically acceptable salt, either alone or in combination with other active agents.
Another significant patent from Koizumi is for the "Uses of benzimidazole derivative for nocturnal acid breakthrough." This innovation pertains to the use of benzimidazole derivative compounds which effectively prevent and treat nocturnal acid breakthrough (NAB). By addressing symptoms related to gastric acid-related diseases, this invention plays a vital role in patient care and management.
Career Highlights: Throughout his career, Shinichi Koizumi has associated himself with notable companies such as Askat Inc. and Raqualia Pharma Inc. His work in these organizations has been pivotal in translating his inventions from concepts into practical applications that address pressing health concerns.
Collaborations: Collaboration is key in innovation, and Koizumi has worked alongside talented colleagues such as Takako Okumura and Kazuhiko Nonomura. Their combined efforts have fostered an environment of creativity and advancement in their respective fields.
Conclusion: Shinichi Koizumi's contributions as an inventor are shaping the future of medical treatments with his innovative patents. His dedication to developing effective solutions for cancer and gastric acid-related diseases signals a promising future for healthcare advancements. As he continues to innovate, the impact of his work is likely to be felt across the medical community and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile